Clinical Trial Update: B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating B memory cell responses to the 13-valent pneumococcal conjugate vaccine in individuals with aspl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asplenia
• Beta Thalassemia Major

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Aghia Sophia Children's Hospital of Athens | Conditions: Asplenia, β-thalassemia Major | Phase 4 | Status: UNKNOWN